| AAA | abdominal aortic aneruysm |
| ALS | amyotrophic lateral sclerosis |
| AngII | angiotensin II |
| APOE | apolioprotein E |
| CAD | coronary artery disease |
| CML | chronic myeloid leukemia |
| DAMP | damage-associated molecular patterns |
| DVT | deep vein thrombosis |
| FADD | FAS-associated death domain |
| HIF1α | hypoxia inducible factor-1α |
| HUVEC | human umbilical vein endothelial cells |
| IFNγ | interferon γ |
| IL1β | Interleukin 1β |
| IVC | inferior vena cava |
| LAD | left anterior descending |
| LDL | low-density lipoprotein |
| LVEF | left ventricle ejection fraction |
| MCAO | middle cerebral artery occlusion |
| MI | myocardial infarction |
| MLKL | mixed-lineage kinase domain like protein |
| MMP | matrix metalloproteinase |
| MS | multiple sclerosis |
| Nec-1/1s | necrostain-1/1s |
| NET | neutrophil extracellular trap |
| NFKβ | Nuclear factor kappa β |
| NSA | necrosulfonamide |
| PCI | percutaneous coronary intervention |
| PE | pulmonary embolism |
| Ph+ ALL | Philadelphia chromosome positive acute lymphoblastic leukemia |
| PI | propidium iodide |
| PTLP | phospholipid transfer protein |
| RA | rheumatoid arthritis |
| RIPK1 | receptor interacting protein kinase 1 |
| RIPK3 | receptor interacting protein kinase 3 |
| SIRS | systemic inflammatory response syndrome |
| SMC | smooth muscle cell |
| STEMI | ST elevation myocardial infarction |
| STING | stimulator of interferon genes |
| TLR 3/4 | toll like receptor 3/4 |
| TNFα | tumor necrosis factor α |
| TNFR1 | tumor necrosis factor receptor 1 |
| TRAILR | tumor necrosis α related apoptosis inducing ligand receptor |
| tPA | tissue plasminogen activator |
| UC | ulcerative colitis |
| VTE | venous thromboembolism |